Cargando…

Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines

(1) Background: Coronavirus disease 2019 (COVID-19) vaccines are currently employed on a population-wide scale in most countries worldwide. Data about unusual cutaneous adverse drug reactions (ADR) are scant, though. (2) Methods: We retrospectively analyzed moderate to severe vaccine-related ADR in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niebel, Dennis, Wenzel, Joerg, Wilsmann-Theis, Dagmar, Ziob, Jana, Wilhelmi, Jasmin, Braegelmann, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544472/ https://www.ncbi.nlm.nih.gov/pubmed/34698094 http://dx.doi.org/10.3390/dermatopathology8040049

Ejemplares similares

Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
por: Niebel, Dennis, et al.
Publicado: (2021)

Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients—Focus on Clinical and Histopathological Variation
por: Niebel, Dennis, et al.
Publicado: (2022)

Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?
por: Niebel, Dennis, et al.
Publicado: (2021)

Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic Approaches
por: Fetter, Tanja, et al.
Publicado: (2020)

Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
por: Niebel, Dennis, et al.
Publicado: (2021)

Specialized dermatological-rheumatological patient management improves diagnostic outcome and patient journey in psoriasis and psoriatic arthritis: a four-year analysis
por: Ziob, Jana, et al.
Publicado: (2021)

Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis—Translation of Pathogenic Fundamentals Into an In Vitro Model
por: Braegelmann, Christine, et al.
Publicado: (2021)

Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus
por: Fetter, Tanja, et al.
Publicado: (2022)

Grzybowski’s Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease—An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case Report
por: Havenith, Regina, et al.
Publicado: (2021)

Cutaneous Adverse Drug Reactions to Targeted Chemotherapeutic Drugs: A Clinico-Epidemiological Study
por: Saini, Kriteeka, et al.
Publicado: (2019)

Cutaneous remnants of the vitellointestinal duct: a clinico-pathological study of 19 cases
por: Heatley, M K, et al.
Publicado: (1988)

Cutaneous Adverse Reactions Associated with COVID-19 Vaccination
por: Jin, Hope, et al.
Publicado: (2023)

Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions
por: Niebel, Dennis, et al.
Publicado: (2023)

The Adverse Impact of the COVID-19 Pandemic on Abdominal Emergencies: A Retrospective Clinico-Pathological Analysis
por: Vissio, Elena, et al.
Publicado: (2021)

Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas
por: Ponti, Giovanni, et al.
Publicado: (2011)

Cutaneous and systemic granulomatosis in ataxia-telangiectasia: a clinico-pathological study
por: Szczawińska-Popłonyk, Aleksandra, et al.
Publicado: (2020)

Clinico-Pathological Features in Köhlmeier–Degos Disease with Cutaneous and Neurological Involvement
por: Sindhu, Dodmallur Mallikarjuna, et al.
Publicado: (2021)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Cutaneous Clinico-Pathological Findings in Three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy
por: GIANOTTI, Raffaele, et al.
Publicado: (2020)

Cutaneous adverse effects of the available COVID-19 vaccines
por: Bogdanov, Georgi, et al.
Publicado: (2021)

Clinico-pathological study of odontomas in 19 Libyan patients
por: Ingafou, Mohamed S. H., et al.
Publicado: (2013)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment
por: Wolk, Kerstin, et al.
Publicado: (2023)

Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
por: FETTER, Tanja, et al.
Publicado: (2020)

Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist
por: Martinez-Lopez, Antonio, et al.
Publicado: (2020)

Prior antihistamine agent successfully impaired cutaneous adverse reactions to COVID‐19 vaccine
por: Nanamori, Hikaru, et al.
Publicado: (2022)

Cutaneous Adverse Drug Reactions (CADRs) to COVID19 Vaccines: A Case Series
por: Purushottam, Manila, et al.
Publicado: (2023)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Rossi, Gabriela, et al.
Publicado: (2021)

Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions
por: Fetter, Tanja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t398lecr98lnv9q15m5pqukvcc